University of California, San Diego (UC San Diego, UCSD)

De novo variants in SNAP25 cause an early-onset developmental and epileptic encephalopathy (2020) Kloeckner C, Sticht H, Zacher P, Popp B, Babcock HE, Bakker DP, Barwick K, et al. Journal article Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results (2020) Fleischer DM, Shreffler WG, Campbell DE, Green TD, Anvari S, Assa'ad A, Bégin P, et al. Journal article Targeting the Wnt signaling pathway through R-spondin 3 identifies an anti-fibrosis treatment strategy for multiple organs (2020) Zhang M, Haughey M, Wang NY, Blease K, Kapoun AM, Couto S, Belka I, et al. Journal article Risk factors and mortality in invasive Rasamsonia spp. infection: Analysis of cases in the FungiScope registry and from the literature (2019) Stemler J, Salmanton-Garcia J, Seidel D, Alexander BD, Bertz H, Hoenigl M, Herbrecht R, et al. Journal article Advances in Understanding High-Mass X-ray Binaries with INTEGRALand Future Directions (2019) Kretschmar P, Furst F, Sidoli L, Bozzo E, Alfonso-Garzon J, Bodaghee A, Chaty S, et al. Journal article Biomechanical signaling within the developing zebrafish heart attunes endocardial growth to myocardial chamber dimensions (2019) Bornhorst D, Xia P, Nakajima H, Dingare C, Herzog W, Lecaudey V, Mochizuki N, et al. Journal article The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice (2019) Engle D, Tiriac H, Rivera K, Pommier A, Whalen S, Oni T, Alagesan B, et al. Conference contribution A Ligand Field Molecular Mechanics Study of CO2-Induced Breathing in the Metal–Organic Framework DUT-8(Ni) (2019) Melix P, Paesani F, Heine T Journal article Matched-paired analysis of patients treated for invasive mucormycosis: Standard treatment versus posaconazole new formulations (MoveOn) (2019) Salmanton-Garcia J, Seidel D, Köhler P, Mellinghoff SC, Herbrecht R, Klimko N, Racil Z, et al. Journal article Early Symptom Improvement With Risankizumab Treatment in Patients With Moderately to Severely Active Crohn's Disease: Analysis From a Phase 2 Study (2019) Feagan BG, Sandborn WJ, D'Haens GR, Panes J, Kaser A, Ferrante M, Louis E, et al. Conference contribution